Global Hormonal Implants 麻豆原创 Research Report 2023

Publication ID:

PB504243706

Publication Date:

April 27, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A Hormonal Implant is an implantable medical device used for the purpose of birth control. The implant may depend on the timed release of hormones to hinder ovulation or sperm development, the ability of copper to act as a natural spermicide within the uterus, or it may work using a non-hormonal, physical blocking mechanism.
Highlights
The global Hormonal Implants market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Hormonal Implants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Hormonal Implants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Hormonal Implants include Bayer HealthCare, Merck, Allergan and Shanghai Dahua Pharmaceuticals, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hormonal Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Implants.
The Hormonal Implants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hormonal Implants market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hormonal Implants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bayer HealthCare
Merck
Allergan
Shanghai Dahua Pharmaceuticals
Segment by Type
Levonorgestrel Hormonal Implants
Etonogestrel Hormonal Implants
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hormonal Implants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hormonal Implants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Hormonal Implants 麻豆原创 Overview
1.1 Product Overview and Scope of Hormonal Implants
1.2 Hormonal Implants Segment by Type
1.2.1 Global Hormonal Implants 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Levonorgestrel Hormonal Implants
1.2.3 Etonogestrel Hormonal Implants
1.3 Hormonal Implants Segment by Application
1.3.1 Global Hormonal Implants 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Hormonal Implants 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Hormonal Implants Revenue 2018-2029
1.4.2 Global Hormonal Implants Sales 2018-2029
1.4.3 Global Hormonal Implants 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hormonal Implants 麻豆原创 Competition by Manufacturers
2.1 Global Hormonal Implants Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Hormonal Implants Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Hormonal Implants Average Price by Manufacturers (2018-2023)
2.4 Global Hormonal Implants Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hormonal Implants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hormonal Implants, Product Type & Application
2.7 Hormonal Implants 麻豆原创 Competitive Situation and Trends
2.7.1 Hormonal Implants 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hormonal Implants Players 麻豆原创 Share by Revenue
2.7.3 Global Hormonal Implants 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hormonal Implants Retrospective 麻豆原创 Scenario by Region
3.1 Global Hormonal Implants 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hormonal Implants Global Hormonal Implants Sales by Region: 2018-2029
3.2.1 Global Hormonal Implants Sales by Region: 2018-2023
3.2.2 Global Hormonal Implants Sales by Region: 2024-2029
3.3 Global Hormonal Implants Global Hormonal Implants Revenue by Region: 2018-2029
3.3.1 Global Hormonal Implants Revenue by Region: 2018-2023
3.3.2 Global Hormonal Implants Revenue by Region: 2024-2029
3.4 North America Hormonal Implants 麻豆原创 Facts & Figures by Country
3.4.1 North America Hormonal Implants 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hormonal Implants Sales by Country (2018-2029)
3.4.3 North America Hormonal Implants Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hormonal Implants 麻豆原创 Facts & Figures by Country
3.5.1 Europe Hormonal Implants 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hormonal Implants Sales by Country (2018-2029)
3.5.3 Europe Hormonal Implants Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hormonal Implants 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Hormonal Implants 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hormonal Implants Sales by Country (2018-2029)
3.6.3 Asia Pacific Hormonal Implants Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hormonal Implants 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Hormonal Implants 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hormonal Implants Sales by Country (2018-2029)
3.7.3 Latin America Hormonal Implants Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hormonal Implants 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Hormonal Implants 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hormonal Implants Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hormonal Implants Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hormonal Implants Sales by Type (2018-2029)
4.1.1 Global Hormonal Implants Sales by Type (2018-2023)
4.1.2 Global Hormonal Implants Sales by Type (2024-2029)
4.1.3 Global Hormonal Implants Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Hormonal Implants Revenue by Type (2018-2029)
4.2.1 Global Hormonal Implants Revenue by Type (2018-2023)
4.2.2 Global Hormonal Implants Revenue by Type (2024-2029)
4.2.3 Global Hormonal Implants Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Hormonal Implants Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hormonal Implants Sales by Application (2018-2029)
5.1.1 Global Hormonal Implants Sales by Application (2018-2023)
5.1.2 Global Hormonal Implants Sales by Application (2024-2029)
5.1.3 Global Hormonal Implants Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Hormonal Implants Revenue by Application (2018-2029)
5.2.1 Global Hormonal Implants Revenue by Application (2018-2023)
5.2.2 Global Hormonal Implants Revenue by Application (2024-2029)
5.2.3 Global Hormonal Implants Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Hormonal Implants Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer HealthCare
6.1.1 Bayer HealthCare Corporation Information
6.1.2 Bayer HealthCare Description and Business Overview
6.1.3 Bayer HealthCare Hormonal Implants Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer HealthCare Hormonal Implants Product Portfolio
6.1.5 Bayer HealthCare Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Hormonal Implants Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Hormonal Implants Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Allergan
6.3.1 Allergan Corporation Information
6.3.2 Allergan Description and Business Overview
6.3.3 Allergan Hormonal Implants Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Allergan Hormonal Implants Product Portfolio
6.3.5 Allergan Recent Developments/Updates
6.4 Shanghai Dahua Pharmaceuticals
6.4.1 Shanghai Dahua Pharmaceuticals Corporation Information
6.4.2 Shanghai Dahua Pharmaceuticals Description and Business Overview
6.4.3 Shanghai Dahua Pharmaceuticals Hormonal Implants Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Dahua Pharmaceuticals Hormonal Implants Product Portfolio
6.4.5 Shanghai Dahua Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hormonal Implants Industry Chain Analysis
7.2 Hormonal Implants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hormonal Implants Production Mode & Process
7.4 Hormonal Implants Sales and 麻豆原创ing
7.4.1 Hormonal Implants Sales Channels
7.4.2 Hormonal Implants Distributors
7.5 Hormonal Implants Customers
8 Hormonal Implants 麻豆原创 Dynamics
8.1 Hormonal Implants Industry Trends
8.2 Hormonal Implants 麻豆原创 Drivers
8.3 Hormonal Implants 麻豆原创 Challenges
8.4 Hormonal Implants 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bayer HealthCare
Merck
Allergan
Shanghai Dahua Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.